Bleomycin-induced pulmonary fibrosis is attenuated by a monoclonal antibody targeting HER2.
about
Pulmonary epithelial barrier function: some new players and mechanismsHuman epidermal growth factor receptor signaling in acute lung injuryMAP3K19 Is a Novel Regulator of TGF-β Signaling That Impacts Bleomycin-Induced Lung Injury and Pulmonary FibrosisThe peripheral blood proteome signature of idiopathic pulmonary fibrosis is distinct from normal and is associated with novel immunological processesBronchoalveolar lavage neuregulin-1 is elevated in acute lung injury and correlates with inflammationMatrix metalloproteinases and protein tyrosine kinases: potential novel targets in acute lung injury and ARDSNeuregulin-1-human epidermal receptor-2 signaling is a central regulator of pulmonary epithelial permeability and acute lung injury.HER2 activation results in β-catenin-dependent changes in pulmonary epithelial permeabilityLipopolysaccharide-induced injury is more pronounced in fetal transgenic ErbB4-deleted lungs.Targeting the TGF-beta1 pathway to prevent normal tissue injury after cancer therapy.The ERBB3 receptor in cancer and cancer gene therapyAirway cells from atopic asthmatic patients exposed to ozone display an enhanced innate immune gene profile.Hepatocyte ERBB3 and EGFR are required for maximal CCl4-induced liver fibrosis.EGF receptor tyrosine kinase inhibitors diminish transforming growth factor-alpha-induced pulmonary fibrosis.ERBB2-induced inflammation in lung carcinogenesis.A role for epidermal growth factor receptor in idiopathic pulmonary fibrosis onsetBleomycin-Induced Lung Injury
P2860
Q26865861-1FA03617-8416-46EA-AC83-5FC97E3B3D93Q27002075-FAFEF326-1903-4EAB-A7AF-754853F0E810Q27348347-D859B5EE-2864-4C40-8B89-3784AFE8AC69Q33601748-F03EEF92-B020-4DD0-A9E1-262BD69B9863Q34073788-AED68949-DFFA-494D-A884-9DD73479A94FQ34299797-D9030E44-5D22-46D8-A78E-C02E8EE898A1Q34695953-5436A0F3-4110-435E-B1C2-D7F4096A5D62Q35115872-EFA650F7-B45A-466D-89DF-EF66DED75ACCQ35325075-33CB190E-F05F-480F-B531-24942C9B75D1Q35583991-29A9BF9E-F236-4425-B0FF-1B3543D8C1FCQ37135372-15B34CDC-1CBC-4D6D-9ADD-5A6F2446AF6BQ40254200-58B4AF82-F804-4A49-9F19-5FD2C9B5B319Q42784235-F793CD3B-9E6D-4A9C-963A-CCE64533A2EDQ46634851-9CA48626-BE41-4C68-8DBC-A41F4AB2249BQ53270838-B5353148-399D-444A-821C-793221BDEC31Q56984392-7E10D09C-0A2F-4F4F-8E00-53997E487B49Q58919755-3A89DEEA-58D9-4B82-BDD0-17864CBA5F6E
P2860
Bleomycin-induced pulmonary fibrosis is attenuated by a monoclonal antibody targeting HER2.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年学术文章
@wuu
2007年学术文章
@zh
2007年学术文章
@zh-cn
2007年学术文章
@zh-hans
2007年学术文章
@zh-my
2007年学术文章
@zh-sg
2007年學術文章
@yue
2007年學術文章
@zh-hant
name
Bleomycin-induced pulmonary fi ...... lonal antibody targeting HER2.
@en
Bleomycin-induced pulmonary fi ...... lonal antibody targeting HER2.
@nl
type
label
Bleomycin-induced pulmonary fi ...... lonal antibody targeting HER2.
@en
Bleomycin-induced pulmonary fi ...... lonal antibody targeting HER2.
@nl
prefLabel
Bleomycin-induced pulmonary fi ...... lonal antibody targeting HER2.
@en
Bleomycin-induced pulmonary fi ...... lonal antibody targeting HER2.
@nl
P2093
P2860
P1476
Bleomycin-induced pulmonary fi ...... lonal antibody targeting HER2.
@en
P2093
Chris L Allen
David E Nethery
Elizabeth F O Kern
Frank J Jacono
Jeffrey A Kern
Jihane A Faress
Rosana Eisenberg
P2860
P304
P356
10.1152/JAPPLPHYSIOL.00239.2007
P407
P577
2007-10-04T00:00:00Z